FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > $HUGE is currently quite undervalued

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Oct 01, 2021 12:12pm

38 Views

Post# 33952573

RE:$HUGE is currently quite undervalued

One other question.....why do you consider HUGE undervalued....no product....no trials.....nothing in development......2 failed endeavours (indoor hydro and FSD 201)......SP down 95%......continuous dilution.....nothing now but hype as part of an acquisition.......what did your DD discover that would lead you to believe this stock is undervalued?......

BobbyAxelrod10 wrote: Investor in psychedelic companies, just took a position in $HUGE yesterday. Looking forward to the positive traction they will get from Lucid acquisition. Lucid looks very promising with its novel compounds. Lucid being part of UHN is a cherry on top.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure